BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10692566)

  • 1. No effect of carvedilol on nitric oxide generation in phagocytes but modulation of production of superoxide ions.
    Asbrink S; Zickert A; Bratt J; Gyllenhammar H; Palmblad J
    Biochem Pharmacol; 2000 Apr; 59(8):1007-13. PubMed ID: 10692566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effect of carvedilol on professional phagocytes.
    Pecivová J; Macicková T; Lojek A; Gallova L; Cíz M; Nosál' R; Holománová D
    Pharmacology; 2007; 79(2):86-92. PubMed ID: 17159380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carvedilol on reactive oxygen species and enzymes linking innate and adaptive immunity.
    Pecivová J; Macicková T; Lojek A; Gallová L; Cíz M; Nosál' R; Holománová D
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():160-3. PubMed ID: 17159805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of superoxide generation and myeloperoxidase release by carvedilol after receptor and nonreceptor stimulation of human neutrophils.
    Macickova T; Pecivova J; Nosal R; Lojek A; Pekarova M; Cupanikova D
    Neuro Endocrinol Lett; 2008 Oct; 29(5):790-3. PubMed ID: 18987595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of carvedilol on superoxide generation and enzyme release from stimulated human neutrophils.
    Macicková T; Pecivová J; Nosál' R; Holománová D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):389-92. PubMed ID: 16601795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils.
    Yue TL; McKenna PJ; Ruffolo RR; Feuerstein G
    Eur J Pharmacol; 1992 Apr; 214(2-3):277-80. PubMed ID: 1355437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin stimulates phosphoinositide turnover and phospholipase C but not phospholipase D and NADPH oxidase in human neutrophils.
    Catz SD; Steŕin-Speziale NB
    J Leukoc Biol; 1996 Apr; 59(4):591-7. PubMed ID: 8613709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.
    Yue TL; Mckenna PJ; Lysko PG; Gu JL; Lysko KA; Ruffolo RR; Feuerstein GZ
    Eur J Pharmacol; 1994 Jan; 251(2-3):237-43. PubMed ID: 8149979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils.
    Yue TL; McKenna PJ; Gu JL; Cheng HY; Ruffolo RE; Feuerstein GZ
    Cardiovasc Res; 1994 Mar; 28(3):400-6. PubMed ID: 7909721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the cellular mechanism of inhibition of formyl-methionyl-leucyl-phenylalanine-induced superoxide anion generation in rat neutrophils by 2-benzyloxybenzaldehyde.
    Wang JP; Chang LC; Lin YL; Hsu MF; Chang CY; Huang LJ; Kuo SC
    Biochem Pharmacol; 2003 Apr; 65(7):1043-51. PubMed ID: 12663040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin does not directly affect neutrophil functions.
    Hojo M; Fujita I; Hamasaki Y; Miyazaki M; Miyazaki S
    Chest; 1994 Feb; 105(2):520-3. PubMed ID: 8306756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nitric oxide in lipoxin A4-induced polymorphonuclear neutrophil-dependent cytotoxicity to human vascular endothelium in vitro.
    Bratt J; Gyllenhammar H
    Arthritis Rheum; 1995 Jun; 38(6):768-76. PubMed ID: 7779119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.
    Wanikiat P; Woodward DF; Armstrong RA
    Br J Pharmacol; 1997 Nov; 122(6):1135-45. PubMed ID: 9401778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity.
    Oettl K; Greilberger J; Zangger K; Haslinger E; Reibnegger G; Jürgens G
    Biochem Pharmacol; 2001 Jul; 62(2):241-8. PubMed ID: 11389884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
    Fantone JC; Marasco WA; Elgas LJ; Ward PA
    Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the new anti-allergic compound ethyl 2-(4'-carboxybenzamido)-4-propionamidobenzoate sodium salt on human neutrophil superoxide production.
    Kaneko M; Suzuki K; Furui H; Takagi K; Satake T
    Arzneimittelforschung; 1990 Jan; 40(1):91-4. PubMed ID: 2160241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of indomethacin against chemotactic deactivation of human neutrophils induced by formylated peptide.
    Perianin A; Gaudry M; Marquetty C; Giroud JP; Hakim J
    Biochem Pharmacol; 1988 May; 37(9):1693-8. PubMed ID: 2837237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 5-aminosalicylic acid and analogous substances on superoxide generation and intracellular free calcium in human neutrophilic granulocytes.
    Nielsen OH; Bouchelouche PN; Berild D; Ahnfelt-Rønne I
    Scand J Gastroenterol; 1993 Jun; 28(6):527-32. PubMed ID: 8100641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human polymorphonuclear leukocyte functions by ibuprofen.
    Nielsen VG; Webster RO
    Immunopharmacology; 1987 Feb; 13(1):61-71. PubMed ID: 3032852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staurosporine and its derivatives enhance f-Met-Leu-Phe-induced superoxide production via phospholipase D activation in human polymorphonuclear leukocytes.
    Mori T; Ando M; Takagi K
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):422-8. PubMed ID: 7981927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.